Has anyone talked to a doctor about the off-label use of Ocrevus, the new MS infusion drug, for CIDP? Expensive drugs are given all the time for conditions they’re not FDA approved for, and insurance usually pays. IVIG, which costs considerably more than Ocrevus, is often prescribed for off-label uses. So why not Ocrevus?